Insulin Drug Offers Hope for MannKind

The launch of Afrezza was a series of botches and errors that would have been at home in an episode of Fawlty Towers . Afrezza is contra-indicated for patients with chronic obstructive pulmonary disease , not surprising since it is absorbed into deep lung tissue.

3 Takeover Candidates in the Drug Space

This commentary originally appeared on Real Money Pro at 7 a.m. ET Friday, Jan. 6. Click here to learn about this dynamic market information service for active traders. We expect quite a number of M&A deals in the health-care sector in 2017.